Consensus Adagene Inc.

Equities

ADAG

US0053291078

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-31 pm EDT			5-day change	1st Jan Change
2.8 ^USD	+7.90%		+8.53%	+44.97%

Mar. 29	Adagene Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 29	Adagene Inc. Announces Board Changes	CI

Evolution of the average Target Price on Adagene Inc.

Price target over the last 5 years

History of analyst recommendation changes

a572ff8f4dc6b31.ztplb9xKOK2KoLnIVgbDr23K4vLv3D2zo7oeIMI_lno.m5cXAYZ_UN_t_9ygBlP75j-Sr5eqjATb8OprdaBr7Eivuz0HmQEO2v6S9A~1e9de17210c1fa17410c90fa623c63e7

Analyst Recommendations on Adagene Inc.

Morgan Stanley Adjusts Price Target on Adagene to $5 From $7, Maintains Overweight Rating	23-01-24	MT
HC Wainwright Starts Adagene at Buy With $5 Price Target	22-12-07	MT
Morgan Stanley Cuts Price Target on Adagene to $7 From $15, Maintains Overweight Rating	22-09-09	MT
Berenberg Emerging Biotech Conference	22-05-18	FA
Morgan Stanley Adjusts Adagene's Price Target to $15 From $27, Reiterates Overweight Rating	22-02-01	MT
Morgan Stanley Adjusts Adagene's Price Target to $27 from $33, Keeps Overweight Rating	22-01-06	MT
ADAGENE : Morgan Stanley Adjusts Price Target on Adagene to $33 From $34, Maintains Overweight Rating	21-07-16	MT
ADAGENE : China Renaissance Starts Adagene at Buy With $40.57 Price Target	21-06-25	MT
ADAGENE : Morgan Stanley Starts Adagene at Overweight With $34 Price Target	21-03-08	MT
ADAGENE : Jefferies & Co Initiates Coverage on Adagene With Buy Rating, $33 Price Target	21-03-08	MT
ADAGENE : Goldman Sachs Initiates Coverage on Adagene With Buy Rating, $29 Price Target	21-03-08	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.8 USD

Average target price

5 USD

Spread / Average Target

+78.57%

High Price Target

5 USD

Spread / Highest target

+78.57%

Low Price Target

5 USD

Spread / Lowest Target

+78.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Adagene Inc.

Morgan Stanley
HC Wainwright
China Renaissance
Jefferies & Co.
Goldman Sachs

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar